<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Biswas I</submitter><funding>NHLBI NIH HHS</funding><pagination>603-616</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cleavage of the extracellular domain of PAR1 (protease-activated receptor 1) by thrombin at Arg41 and by APC (activated protein C) at Arg46 initiates paradoxical cytopathic and cytoprotective signaling in endothelial cells. In the latter case, the ligand-dependent coreceptor signaling by EPCR (endothelial protein C receptor) is required for the protective PAR1 signaling by APC. Here, we investigated the role of thrombomodulin in determining the specificity of PAR1 signaling by thrombin.&lt;h4>Methods&lt;/h4>We prepared a PAR1 knockout (PAR1&lt;sup>-/-&lt;/sup>) EA.hy926 endothelial cell line by CRISPR/Cas9 and transduced PAR1&lt;sup>-/-&lt;/sup> cells with lentivirus vectors expressing PAR1 mutants in which either Arg41 or Arg46 was replaced with an Ala. Furthermore, human embryonic kidney 293 cells were transfected with wild-type or mutant PAR1 cleavage reporter constructs carrying N-terminal Nluc (NanoLuc luciferase) and C-terminal enhanced yellow fluorescent protein tags.&lt;h4>Results&lt;/h4>Characterization of transfected cells in signaling and receptor cleavage assays revealed that, upon interaction with thrombomodulin, thrombin cleaves Arg46 to elicit cytoprotective effects by a β-arrestin-2 biased signaling mechanism. Analysis of functional data and cleavage rates indicated that thrombin-thrombomodulin cleaves Arg46>10-fold faster than APC. Upon interaction with thrombin, the cytoplasmic domain of thrombomodulin recruited both β-arrestin-1 and -2 to the plasma membrane. Thus, the thrombin cleavage of Arg41 was also cytoprotective in thrombomodulin-expressing cells by β-arrestin-1-biased signaling. APC in the absence of EPCR cleaved Arg41 to initiate disruptive signaling responses like thrombin.&lt;h4>Conclusions&lt;/h4>These results suggest that coreceptor signaling by thrombomodulin and EPCR determines the PAR1 cleavage and signaling specificity of thrombin and APC, respectively.</pubmed_abstract><journal>Arteriosclerosis, thrombosis, and vascular biology</journal><pubmed_title>Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin.</pubmed_title><pmcid>PMC10922642</pmcid><funding_grant_id>R01 HL101917</funding_grant_id><pubmed_authors>Giri H</pubmed_authors><pubmed_authors>Biswas I</pubmed_authors><pubmed_authors>Rezaie AR</pubmed_authors><pubmed_authors>Panicker SR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin.</name><description>&lt;h4>Background&lt;/h4>Cleavage of the extracellular domain of PAR1 (protease-activated receptor 1) by thrombin at Arg41 and by APC (activated protein C) at Arg46 initiates paradoxical cytopathic and cytoprotective signaling in endothelial cells. In the latter case, the ligand-dependent coreceptor signaling by EPCR (endothelial protein C receptor) is required for the protective PAR1 signaling by APC. Here, we investigated the role of thrombomodulin in determining the specificity of PAR1 signaling by thrombin.&lt;h4>Methods&lt;/h4>We prepared a PAR1 knockout (PAR1&lt;sup>-/-&lt;/sup>) EA.hy926 endothelial cell line by CRISPR/Cas9 and transduced PAR1&lt;sup>-/-&lt;/sup> cells with lentivirus vectors expressing PAR1 mutants in which either Arg41 or Arg46 was replaced with an Ala. Furthermore, human embryonic kidney 293 cells were transfected with wild-type or mutant PAR1 cleavage reporter constructs carrying N-terminal Nluc (NanoLuc luciferase) and C-terminal enhanced yellow fluorescent protein tags.&lt;h4>Results&lt;/h4>Characterization of transfected cells in signaling and receptor cleavage assays revealed that, upon interaction with thrombomodulin, thrombin cleaves Arg46 to elicit cytoprotective effects by a β-arrestin-2 biased signaling mechanism. Analysis of functional data and cleavage rates indicated that thrombin-thrombomodulin cleaves Arg46>10-fold faster than APC. Upon interaction with thrombin, the cytoplasmic domain of thrombomodulin recruited both β-arrestin-1 and -2 to the plasma membrane. Thus, the thrombin cleavage of Arg41 was also cytoprotective in thrombomodulin-expressing cells by β-arrestin-1-biased signaling. APC in the absence of EPCR cleaved Arg41 to initiate disruptive signaling responses like thrombin.&lt;h4>Conclusions&lt;/h4>These results suggest that coreceptor signaling by thrombomodulin and EPCR determines the PAR1 cleavage and signaling specificity of thrombin and APC, respectively.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-18T21:18:03.064Z</modification><creation>2025-04-07T09:15:21.329Z</creation></dates><accession>S-EPMC10922642</accession><cross_references><pubmed>38174561</pubmed><doi>10.1161/ATVBAHA.123.320185</doi><doi>10.1161/atvbaha.123.320185</doi></cross_references></HashMap>